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ABSTRACT
Introductions: Guidelines on antibiotics use in surgical patients recommends a 
single dose prophylaxis for clean-contaminated cases and therapeutic course 
for contaminated and dirty cases. Compliance to this guideline is poor among 
diabetic patients. The aim of this study was to test the efficacy of single dose 
antibiotic prophylaxis on the occurrence of postoperative surgical site infection 
(SSI) in clean-contaminated surgery in diabetic patients.
Methods: Retrospective cross-sectional study was carried out at KIST Medical 
College and Teaching Hospital from September 2008 to August 2012 involving 
144 diabetic patients who underwent major clean-contaminated surgery. Forty 
eight patients received one gram of ceftriaxone intravenously as prophylactic 
antibiotic within 30 minutes prior to incision (group 1) and 96 patients received 
three doses of ceftriaxone (group 2). One dose was given within 30 minutes 
prior to incision and other two doses were given postoperatively. All patients 
were followed up for 30 postoperative days on outpatient basis. The SSI rates 
were compared in two groups. Pus from the infected wound was tested for 
culture and sensitivity. 
Results: The SSI rates in group 1 and group 2 were of 5/48 (10.42%) and of 9/96 
(9.37%) respectively. There was no significant difference in SSI rates between 
group 1 and group 2 (p=0.322). 
Conclusions: Single dose of Ceftriaxone shows the similar effect as three doses 
in clean-contaminated surgery in diabetic patients. 
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Plain Language Summary 
The study showed that a single dose of Ceftriaxone has the similar effect as 
three doses in clean-contaminated surgery in diabetic patients. A single dose of 
Ceftriaxone within 30 minutes prior to incision had equal efficacy as three doses.
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INTRODUCTIONS
Patients with surgical site infections (SSI) have prolonged 
hospital stay, re-hospitalization, increased morbidity 
and mortality, and high costs of treatment.1 Surgical 
antibiotic prophylaxis (SAP) is given to reduce surgical 
SSI based on evidence of effectiveness, minimizing 
the alteration on the patient’s normal bacterial flora, 
minimizing adverse effects and causing minimal change 
to the patient’s host defences.2 A single standard 
intravenous therapeutic dose of antibiotic is given 
≤30 minutes pre-operatively3,4 and is recommended 
for  all elective operations in the clean-contaminated 
or contaminated categories regardless of the presence 
of risk factors.2 Though we are all aware of these 
guidelines, compliance is poor. The aim of this study 
was to test the efficacy of a single dose of Ceftriaxone 
prophylaxis in clean-contaminated surgery among 
diabetic patients.
METHODS
The retrospective cross-sectional study was carried 
out at KIST Medical College and Teaching Hospital, 
Lalitpur, Nepal from September 2008 to August 2012 
involving 144 diabetic patients of all age groups and 
gender who underwent major clean-contaminated 
surgery. The procedures were gastrectomy, 
hemicolectomy, laparoscopic appendectomy, 
laparoscopic cholecystectomy, laparotomy, 
nephrectomy, nephrolithotomy, open appendectomy, 
open cholecystectomy, open cholecystectomy with 
common bile duct exploration, pyelolithotomy and 
retropubic prostatectomy. All the above procedures 
were completed within three hours. 
The patients who missed follow up for 30 post operative 
days were excluded from the study. The inclusion 
criteria were categorized into two groups. Some 
surgeons preferred single dose and others three doses 
of antibiotics in the same department. Among them, 48 
patients received one gram of ceftriaxone intravenously 
as prophylactic antibiotic within 30 minutes prior 
to incision (group 1) and 96 patients received three 
doses of ceftriaxone (group 2), out of which one dose 
was given within 30 minutes prior to incision and 
other two doses were given postoperatively at twelve 
hours interval. Ethical approval was taken from the 
institutional review board. 
Patients were followed for 30 postoperative days.5 
Those patients who had SSI were followed up 
frequently for the management of SSI. Those patients 
who did not have SSI at the time of suture removal on 
7th to 9th post-operative day were told to follow up for 
wound discharge, redness or pain any time and after 
one month even if there was no sign of SSI. The patients 
were followed up on outpatient basis. The SSI rates 
were calculated and compared in two groups. Pus or pus 
swabs of the patient with discharging surgical incision 
were obtained and transported to the laboratory within 
an hour of collection. 
After identification of the organism, susceptibility 
testing to various antibiotics was performed using disc 
diffusion methods.6 Data were analyzed using Statistical 
Package for Social Sciences (SPSS) 20. Paired sample 
t-test was used in process of data analysis. A p-value 
less than 0.05 was considered as statistically significant.
RESULTS
There were total of 144 patients, 48 in group 1 (single 
dose ceftriaxone) and 96 in group 2 three doses. The 
mean age of the patients in group 1 was 53.27 ± 15.89 
years (mean ± SD) and in group 2 was 51.45 ± 13.14 
years (mean ± SD).  
Table 1.  Major surgical intervention in diabetic patients 
(n=144) and SSI
Variables
Single dose of 
ceftriaxone
Three doses of 
ceftriaxone
Frequency % Frequency %
Type of operation
Laparoscopic 
cholecystectomy 20 41.7 37 38.5
Retropubic 
Prostatectomy 2 4.2 3 3.1
Open cholecystectomy 9 18.8 17 17.7
Pyelolithotomy 5 10.4 9 9.4
Laparotomy 5 10.4 9 9.4
Gastrectomy 2 4.2 2 2.1
Open appendectomy 3 6.3 9 9.4
Open cholecystectomy 
with Common Bile Duct 
exploration
0 0 4 4.2
Nephrectomy 1 2.1 2 2.1
Nephrolithotomy 0 0 2 2.1
Laparoscopic 
appendectomy 0 0 2 2.1
Hemicolectomy 1 2.1 0 0
Total 48 100 96 100
SSI
No SSI 43 89.6 87 90.6
SSI 5 10.4 9 9.4
ssi= surgical site infections
Among 14 patients with clinical SSI in group one and 
two, nine (64.29%) had positive aerobic culture. 
Staphylococcus aureus was the predominant organism 
isolated in 5/9 (55.56%) followed by Escherichia coli 
isolated in 2/9 (22.22%) cases and 60.31% of total 
isolates (including all organisms) were sensitive to 
ceftriaxone.
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DISCUSSIONS
There was no significant difference in SSI rates 
between group 1 and when the SSI rates before the 
era of prophylactic antibiotics and after its use are 
compared, we can see the positive role of prophylactic 
antibiotics in reducing the SSI rates.7,8 Infection rates 
after prophylactic antibiotics in US National Nosocomial 
Infection Surveillance (NNIS) system hospitals were 
reported to be: clean 2.1%, clean-contaminated 3.3%, 
contaminated 6.4% and dirty 7.1%.7 In our study, we 
observed the higher SSI rates compared to the USNNIS 
lower than studies with 5.4%, 35.5% and 77.8% in 
clean, clean-contaminated and contaminated wounds 
respectively.9,10 We observed no significant difference 
in SSI rates being 10.42% and 9.37% among clean-
contaminated cases in single dose SAP and prolonged 
course group respectively.
Laparoscopic cholecystectomy was the commonest 
clean-contaminated operation (24% of clean-
contaminated operations).11 The duration of the 
majority of surgical operations (88.4%) did not exceed 
three hours.11 In our study also, the procedures were 
performed within three hours and the most commonly 
performed clean-contaminated operation was 
laparoscopic cholecystectomy.
In our study, Staphylococcus aureus was found to be 
the predominant organism followed by Escherichia 
coli. Similar results were seen in other studies.10 Out 
of total isolates (including all organisms), 60.31% were 
sensitive to ceftriaxone in our study. Other studies 
have also shown ceftriaxone to be superior than other 
cephalosporins and other antibiotics in the use for 
prophylaxis.12,13
There are multiple risk factors for SSI such as extremes 
of age, poor nutritional state, obesity, diabetes mellitus, 
smoking, coexisting infections at other sites, bacterial 
colonization, immunosuppression etc. The guidelines 
recommend only a single dose of antibiotic in clean-
contaminated cases regardless of the presence of risk 
factors.2 In our study also, we have found the similar 
results.
CONCLUSIONS
Single dose of Ceftriaxone shows the similar effect as 
three doses in clean-contaminated surgery in diabetic 
patients. 
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